These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31176541)

  • 41. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: serologic tests.
    Jones LM; García-Carrillo C; Alton GG
    Am J Vet Res; 1973 Feb; 34(2):199-202. PubMed ID: 4631096
    [No Abstract]   [Full Text] [Related]  

  • 42. The NOD-
    Khalaf OH; Chaki SP; Garcia-Gonzalez DG; Ficht TA; Arenas-Gamboa AM
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Brucella at the dawn of the third milenium: genomic organization and pathogenesis].
    Michaux-Charachon S; Foulongne V; O'Callaghan D; Ramuz M
    Pathol Biol (Paris); 2002 Jul; 50(6):401-12. PubMed ID: 12168259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.
    Gomez G; Adams LG; Rice-Ficht A; Ficht TA
    Front Cell Infect Microbiol; 2013; 3():17. PubMed ID: 23720712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.
    Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV
    Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.
    de Souza Filho JA; de Paulo Martins V; Campos PC; Alves-Silva J; Santos NV; de Oliveira FS; Menezes GB; Azevedo V; Cravero SL; Oliveira SC
    Infect Immun; 2015 Apr; 83(4):1458-64. PubMed ID: 25644010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of vaccines and of antigen therapy in a mouse model for Brucella ovis.
    Jiménez de Bagüés MP; Marín CM; Barberán M; Blasco JM
    Vaccine; 1993; 11(1):61-6. PubMed ID: 8427038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in Brucella abortus vaccines.
    Dorneles EM; Sriranganathan N; Lage AP
    Vet Res; 2015 Jul; 46(1):76. PubMed ID: 26155935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century.
    Godfroid J; Scholz HC; Barbier T; Nicolas C; Wattiau P; Fretin D; Whatmore AM; Cloeckaert A; Blasco JM; Moriyon I; Saegerman C; Muma JB; Al Dahouk S; Neubauer H; Letesson JJ
    Prev Vet Med; 2011 Nov; 102(2):118-31. PubMed ID: 21571380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brucella abortus S19 and RB51 vaccine immunogenicity test: Evaluation of three mice (BALB/c, Swiss and CD-1) and two challenge strains (544 and 2308).
    Miranda KL; Dorneles EM; Pauletti RB; Poester FP; Lage AP
    Vaccine; 2015 Jan; 33(4):507-11. PubMed ID: 25498211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptome analysis of gene expression profiling of infected macrophages between Brucella suis 1330 and live attenuated vaccine strain S2 displays mechanistic implication for regulation of virulence.
    Jiang H; Dong H; Peng X; Feng Y; Zhu L; Niu K; Peng Y; Fan H; Ding J
    Microb Pathog; 2018 Jun; 119():241-247. PubMed ID: 29626657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
    Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brucella melitensis M5-90Δbp26 as a potential live vaccine that allows for the distinction between natural infection and immunization.
    Li T; Tong Z; Huang M; Tang L; Zhang H; Chen C
    Can J Microbiol; 2017 Aug; 63(8):719-729. PubMed ID: 28482164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statistical procedures for calculating the residual virulence of Brucella abortus strain 19 (S19) and Brucella melitensis strain Rev 1 vaccines in mice: theoretical basis and practical applications.
    Pouillot R; Grilló MJ; Alabart JL; Garin-Bastuji B; Blasco JM
    Rev Sci Tech; 2003 Dec; 22(3):1051-63. PubMed ID: 15005562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rough Brucella neotomae provides protection against Brucella suis challenge in mice.
    Jain-Gupta N; Waldrop SG; Tenpenny NM; Witonsky SG; Boyle SM; Sriranganathan N
    Vet Microbiol; 2019 Dec; 239():108447. PubMed ID: 31767087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of Brucella melitensis Rev.1 vaccine-strain genetic markers: Towards understanding the molecular mechanism behind virulence attenuation.
    Issa MN; Ashhab Y
    Vaccine; 2016 Sep; 34(41):4884-4891. PubMed ID: 27595444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo.
    Caporale V; Bonfini B; Di Giannatale E; Di Provvido A; Forcella S; Giovannini A; Tittarelli M; Scacchia M
    Vet Ital; 2010; 46(1):13-9, 5-11. PubMed ID: 20391363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Virulence factors in brucellosis: implications for aetiopathogenesis and treatment.
    Fugier E; Pappas G; Gorvel JP
    Expert Rev Mol Med; 2007 Dec; 9(35):1-10. PubMed ID: 18088444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.